Clene Inc. Common Stock
Symbol: CLNN (NASDAQ)
8.19
▼ (-5.03%) -0.434
Company Description:
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.
Key Stats
- Today's Open: $8.56
- Today's High: $8.44
- Today's Low: $7.69
- Today's Volume: 57.16K
- Yesterday Close: $8.62
- Yesterday High: $8.8399
- Yesterday Low: $7.97
- Yesterday Volume: 60.49K
- Last Min Volume: 0
- Last Min High: $8.188
- Last Min Low: $8.186
- Last Min VWAP: $0
Company Profile
- Name: Clene Inc. Common Stock
- Website: https://www.clene.com
- Listed Date: 2020-12-31
- Location: SALT LAKE CITY, UT
- Market Status: Active
- CIK Number: 0001822791
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $86.80M
- Round Lot: 100
- Outstanding Shares: 10.07M
- Asset Type: CS
RECENT FILINGS FOR CLNN
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-10-17 | 8-K | View |
| 2025-10-17 | 424B5 | View |
| 2025-10-14 | 8-K | View |
| 2025-09-30 | 4/A | View |
| 2025-09-30 | 4/A | View |
| 2025-09-30 | 4/A | View |
| 2025-09-29 | 4 | View |
| 2025-09-29 | 4 | View |
| 2025-09-29 | 4 | View |
| 2025-09-25 | 8-K | View |
| 2025-09-19 | 4 | View |
| 2025-09-19 | 4 | View |
| 2025-09-19 | 4 | View |
| 2025-09-12 | EFFECT | View |
| 2025-09-12 | 424B3 | View |
| 2025-09-05 | 8-K | View |
| 2025-09-05 | 424B5 | View |
| 2025-09-05 | S-3 | View |
| 2025-09-05 | S-8 | View |
| 2025-08-21 | 4 | View |
Latest News on CLNN